The genetic testing market reached a value of nearly $15,363.4 million in 2022, having grown at a compound annual growth rate (CAGR) of 7.5% since 2017. The market is expected to grow from $15,363.4 million in 2022 to $25,086.7 million in 2027 at a rate of 10.3%. The market is then expected to grow at a CAGR of 9.0% from 2027 and reach $38,554.6 million in 2032.
Growth in the historic period resulted from increasing healthcare expenditure, rise in cancer prevalence, increase in demand for personalized medicine and emergence of novel infectious diseases. Factors that negatively affected growth in the historic period were low healthcare access, challenges due to regulatory changes, high costs of genetic testing and coronavirus pandemic.
Going forward, increasing government support, rising prevalence of genetic disorders, rising geriatric population and increase in chronic diseases prevalence will drive the growth. Factors that could hinder the growth of the genetic testing market in the future include limited number of testing centers and lack of skilled/trained molecular biologists.
The genetic testing market is segmented by type into predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomic testing and other types. The prenatal and newborn testing market was the largest segment of the genetic testing market segmented by type, accounting for 30.1% of the total in 2022. Going forward, the predictive testing segment is expected to be the fastest growing segment in the genetic testing market segmented by type, at a CAGR of 11.0% during 2022-2027.
The genetic testing market is also segmented by technology into cytogenetic testing, biochemical testing and molecular testing. The molecular testing market was the largest segment of the genetic testing market segmented by technology, accounting for 56.9% of the total in 2022. Going forward, the cytogenetic testing segment is expected to be the fastest growing segment in the genetic testing market segmented by technology, at a CAGR of 10.8% during 2022-2027.
The genetic testing market is also segmented by application into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis and other applications. The cancer diagnosis market was the largest segment of the genetic testing market segmented by application, accounting for 45.2% of the total in 2022. Going forward, the cancer diagnosis segment is expected to be the fastest growing segment in the genetic testing market segmented by application, at a CAGR of 10.6% during 2022-2027.
The genetic testing market is also segmented by end user into hospitals and clinics, diagnostic laboratories and centers and other end users. The hospitals and clinics market was the largest segment of the genetic testing market segmented by end user, accounting for 42.0% of the total in 2022. Going forward, the other end users segment is expected to be the fastest growing segment in the genetic testing market segmented by end user, at a CAGR of 10.6% during 2022-2027.
North America was the largest region in the genetic testing market, accounting for 43.7% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the genetic testing market will be Asia Pacific and North America where growth will be at CAGRs of 11.1% and 10.4% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 10.0% and 9.4% respectively.
The Global genetic testing market is fragmented, with a large number of players. The top ten competitors in the market made up to 22.79% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Myriad Genetics Inc. was the largest competitor with 3.77% share of the market, followed by Illumina Inc. with 3.63%, Abbott Laboratories with 2.60%, Eurofins Scientific with 2.45%, Danaher Corporation with 2.15%, F. Hoffmann-La Roche Ltd with 2.07%, Quest Diagnostics Incorporated with 2.07%, Qiagen NV with 1.67%, Thermo Fisher Scientific Inc. with 1.62%, and BioRad Laboratories Inc. with 0.77%.
The top opportunities in the genetic testing market segmented by type will arise in the prenatal and newborn testing segment, which will gain $3,028.3 million of global annual sales by 2027. The top opportunities in the genetic testing market segmented by technology will arise in the molecular testing segment, which will gain $5,505.4 million of global annual sales by 2027. The top opportunities in the genetic testing market segmented by application will arise in the cancer diagnosis segment, which will gain $4,553.6 million of global annual sales by 2027. The top opportunities in the genetic testing market segmented by end user will arise in the hospitals and clinics segment, which will gain $3,929.4 million of global annual sales by 2027. The genetic testing market size will gain the most in the USA at $4,058.6 million.
Market-trend-based strategies for the genetic testing market includes introducing new programs such as genetic counseling and informatics programs that will assist develop the next generation of genetic testing, technological advancement and launching direct-to-consumer genetic tests.
Player-adopted strategies in the genetic testing market includes expanding genetic testing portfolio through introduction of additional testing platforms, reducing the turnaround time of DNA sequencing through the launch of new products, diversifying business through strategic acquisitions and enhancing business capabilities through receiving regulatory approvals.
To take advantage of the opportunities, the publisher recommends the genetic testing companies to focus on introducing new programs, focus on technology advancements, increase focus on direct-to-consumer genetic tests, expand in developed markets, focus on strategic collaborations and acquisitions, provide competitively priced offerings, participate in medicine seminars and conferences, target hospitals and pharmacies to spread awareness, continue to target fast-growing end-users.
This report describes and explains the genetic testing market and covers 2017 to 2022, termed the historic period, and 2022 to 2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from increasing healthcare expenditure, rise in cancer prevalence, increase in demand for personalized medicine and emergence of novel infectious diseases. Factors that negatively affected growth in the historic period were low healthcare access, challenges due to regulatory changes, high costs of genetic testing and coronavirus pandemic.
Going forward, increasing government support, rising prevalence of genetic disorders, rising geriatric population and increase in chronic diseases prevalence will drive the growth. Factors that could hinder the growth of the genetic testing market in the future include limited number of testing centers and lack of skilled/trained molecular biologists.
The genetic testing market is segmented by type into predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomic testing and other types. The prenatal and newborn testing market was the largest segment of the genetic testing market segmented by type, accounting for 30.1% of the total in 2022. Going forward, the predictive testing segment is expected to be the fastest growing segment in the genetic testing market segmented by type, at a CAGR of 11.0% during 2022-2027.
The genetic testing market is also segmented by technology into cytogenetic testing, biochemical testing and molecular testing. The molecular testing market was the largest segment of the genetic testing market segmented by technology, accounting for 56.9% of the total in 2022. Going forward, the cytogenetic testing segment is expected to be the fastest growing segment in the genetic testing market segmented by technology, at a CAGR of 10.8% during 2022-2027.
The genetic testing market is also segmented by application into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis and other applications. The cancer diagnosis market was the largest segment of the genetic testing market segmented by application, accounting for 45.2% of the total in 2022. Going forward, the cancer diagnosis segment is expected to be the fastest growing segment in the genetic testing market segmented by application, at a CAGR of 10.6% during 2022-2027.
The genetic testing market is also segmented by end user into hospitals and clinics, diagnostic laboratories and centers and other end users. The hospitals and clinics market was the largest segment of the genetic testing market segmented by end user, accounting for 42.0% of the total in 2022. Going forward, the other end users segment is expected to be the fastest growing segment in the genetic testing market segmented by end user, at a CAGR of 10.6% during 2022-2027.
North America was the largest region in the genetic testing market, accounting for 43.7% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the genetic testing market will be Asia Pacific and North America where growth will be at CAGRs of 11.1% and 10.4% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 10.0% and 9.4% respectively.
The Global genetic testing market is fragmented, with a large number of players. The top ten competitors in the market made up to 22.79% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Myriad Genetics Inc. was the largest competitor with 3.77% share of the market, followed by Illumina Inc. with 3.63%, Abbott Laboratories with 2.60%, Eurofins Scientific with 2.45%, Danaher Corporation with 2.15%, F. Hoffmann-La Roche Ltd with 2.07%, Quest Diagnostics Incorporated with 2.07%, Qiagen NV with 1.67%, Thermo Fisher Scientific Inc. with 1.62%, and BioRad Laboratories Inc. with 0.77%.
The top opportunities in the genetic testing market segmented by type will arise in the prenatal and newborn testing segment, which will gain $3,028.3 million of global annual sales by 2027. The top opportunities in the genetic testing market segmented by technology will arise in the molecular testing segment, which will gain $5,505.4 million of global annual sales by 2027. The top opportunities in the genetic testing market segmented by application will arise in the cancer diagnosis segment, which will gain $4,553.6 million of global annual sales by 2027. The top opportunities in the genetic testing market segmented by end user will arise in the hospitals and clinics segment, which will gain $3,929.4 million of global annual sales by 2027. The genetic testing market size will gain the most in the USA at $4,058.6 million.
Market-trend-based strategies for the genetic testing market includes introducing new programs such as genetic counseling and informatics programs that will assist develop the next generation of genetic testing, technological advancement and launching direct-to-consumer genetic tests.
Player-adopted strategies in the genetic testing market includes expanding genetic testing portfolio through introduction of additional testing platforms, reducing the turnaround time of DNA sequencing through the launch of new products, diversifying business through strategic acquisitions and enhancing business capabilities through receiving regulatory approvals.
To take advantage of the opportunities, the publisher recommends the genetic testing companies to focus on introducing new programs, focus on technology advancements, increase focus on direct-to-consumer genetic tests, expand in developed markets, focus on strategic collaborations and acquisitions, provide competitively priced offerings, participate in medicine seminars and conferences, target hospitals and pharmacies to spread awareness, continue to target fast-growing end-users.
This report describes and explains the genetic testing market and covers 2017 to 2022, termed the historic period, and 2022 to 2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Genetic Testing Market Definition And Segmentations
6.4. Market Segmentation By Type
6.4.1. Predictive Testing
6.4.2. Carrier Testing
6.4.3. Prenatal And Newborn Testing
6.4.4. Diagnostic Testing
6.4.5. Pharmacogenomics Testing
6.4.6. Nutrigenomic Testing
6.4.7. Other Types
6.5. Market Segmentation By Technology
6.5.1. Cytogenetic Testing
6.5.2. Biochemical Testing
6.5.3. Molecular Testing
6.6. Market Segmentation By Application
6.6.1. Cancer Diagnosis
6.6.2. Cardiovascular Disease Diagnosis
6.6.3. Other Applications
6.7. Market Segmentation By End User
6.7.1. Hospitals And Clinics
6.7.2. Diagnostic Laboratories And Centres
6.7.3. Other End Users
7. Major Market Trends
7.1. Introducing New Programs
7.2. Technology Advancements
7.3. Direct-to-Consumer Genetic Tests
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
8.2.1. Market Drivers 2017 - 2022
8.2.2. Market Restraints 2017 - 2022
8.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 - 2027
8.3.2. Market Restraints 2022 - 2027
9. Global Genetic Testing Market Segmentation
9.1. Global Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Genetic Testing Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10. Genetic Testing Market, Regional and Country Analysis
10.1. Global Genetic Testing Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Genetic Testing Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.4. Asia-Pacific Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Genetic Testing Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government initiatives
11.11.5. Regulations
11.11.6. Regulatory bodies
11.11.7. Major Associations
11.11.8. Taxes levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.13. China Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.14. China Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.15. China Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.16. China Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.19. India Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.20. India Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.21. India Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.22. India Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.25. Japan Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.26. Japan Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.31. Australia Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.32. Australia Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.37. Indonesia Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.38. Indonesia Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.43. South Korea Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.44. South Korea Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes levied
12.2.9. Corporate tax structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.4. Western Europe Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.5. Western Europe Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Genetic Testing Market: Country Analysis
12.9. UK Market
12.10. UK Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.11. UK Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.12. UK Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.17. Germany Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.18. Germany Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.23. France Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.24. France Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.25. France Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.26. France Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.4. Eastern Europe Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.5. Eastern Europe Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Genetic Testing Market: Country Analysis
13.9. Russia Market
13.10. Russia Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.11. Russia Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.12. Russia Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.4. North America Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.5. North America Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Genetic Testing Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.13. USA Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.14. USA Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Association
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.4. South America Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.5. South America Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Genetic Testing Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.11. Brazil Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.12. Brazil Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
16.4. Middle East Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
16.5. Middle East Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Genetic Testing Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
17.4. Africa Genetic Testing Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
17.5. Africa Genetic Testing Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Genetic Testing Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Genetic Testing Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Myriad Genetics Inc
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Illumina Inc
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Abbott Laboratories
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Financial Overview
18.5. Eurofins Scientific SE
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Danaher Corporation
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers and Acquisitions
19.1. Myriad Genetics, Inc. Acquired Gateway Genomics, LLC
19.2. Sinopharm Acquired BBI Life Sciences
19.3. Kindbody Acquired Phosphorus Labs
19.4. PrivaPath Diagnostics Limited Acquired Veritas Genetics Inc.
19.5. Eurofins acquired GENTIS
19.6. Sema4 Acquired GeneDx
19.7. Exact Sciences Acquired Prevention Genetics
19.8. Eurofins Scientific Acquired Genetic Lab
19.9. 23andme Holding Co. Merged With VG Acquisition Corp.
19.10. Blackstone Acquired Ancestry.com
19.11. Quest Diagnostics Acquired Blueprint Genetics
20. Opportunities And Strategies
20.1. Global Genetic Testing Market In 2027 - Countries Offering Most New Opportunities
20.2. Global Genetic Testing Market In 2027 - Segments Offering Most New Opportunities
20.3. Global Genetic Testing Market In 2027 - Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Genetic Testing Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. About the Publisher
22.5. Copyright and Disclaimer
Executive Summary
Genetic Testing Global Market Opportunities And Strategies To 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global genetic testing market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider genetic testing market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics
- Key Trends
- Global Market Size and Growth
- Regional Analysis
- Market Segmentation
- Regional Market Size and Growth
- Competitive Landscape
- Key Mergers and Acquisitions
- Market Opportunities And Strategies
- Conclusions And Recommendations
- Appendix
Scope
Markets Covered
1) By Type: Predictive Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomics Testing; Nutrigenomic Testing; Other Types2) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing
3) By Application: Cancer Diagnosis; Genetic Disease Diagnosis; Cardiovascular Disease Diagnosis; Other Applications
4) By End User: Hospitals And Clinics; Diagnostic Laboratories And Centres; Other End Users
Companies Mentioned: Myriad Genetics Inc; Illumina Inc; Abbott Laboratories; Eurofins Scientific; Danaher Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; genetic testing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Myriad Genetics Inc
- Illumina Inc
- Abbott Laboratories
- Eurofins Scientific
- Danaher Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 308 |
| Published | February 2023 |
| Forecast Period | 2022 - 2032 |
| Estimated Market Value ( USD | $ 15363.4 Million |
| Forecasted Market Value ( USD | $ 38554.6 Million |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 5 |
